New FDA-Approved Treatments for MS
Dr. Rae Bacharach discusses two new, disease-modifying therapies for use in multiple sclerosis.
25 Huhti 20191min
Continuum Pearls: Transient Epileptic Amnesia
Dr. Gregory Day discusses the recognition of transient epileptic amnesia. To learn more, read Dr. Day's article, "Reversible Dementias," in the February 2019 Dementia issue of Continuum.
24 Huhti 20191min
Montreal Cognitive Assessment as a screening tool: Influence of performance and symptom validity
Dr. Brigid Waldron-Perrine talks about the Montreal Cognitive Assessment as a screening tool.
23 Huhti 20191min
Use of Neurofilament Light as a Potential Biomarker for Alzheimer's Disease
Dr. Mathias Jucker discusses the use of neurofilament light as a potential biomarker for Alzheimer's Disease.
22 Huhti 20191min
Continuum Pearls: Behavioral Variant Frontotemporal Dementia
Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum, discusses behavioral-variant frontotemporal dementia. To learn more, read the article "Behavioral Variant Fro...
17 Huhti 20191min
The comparative effectiveness of teriflunomide and dimethyl fumarate
Dr. Mathias Buron discusses the takeaways from his paper the comparative effectiveness of teriflunomide and dimethyl fumarate.
16 Huhti 20191min
Joanna Hellmuth: The Rise of Pseudomedicine for Dementia and Brain Health
Dr. Joanna Hellmuth discusses the findings of her paper on the rise of pseudomedicine for dementia and brain health.
15 Huhti 20191min
65-year-old female with subacute hemiballism
Dr. Roy Strowd discusses a recent Clinical Reasoning case about a 65-year-old female with subacute hemiballism.
11 Huhti 20191min
